glp 1 and potassium GLP-1 receptor agonists next-generation metabolic hormone therapies in chronic kidney disease GLP-1R signalling promotes β-cell glucose

Understanding the evidence helps you make an informed choice about when to start GLP-1 therapy and how to prioritize both your health and your nursing infant's safety

Your provider must document BMI, relevant comorbidities (diabetes, hypertension, cardiovascular markers), and why GLP-1 therapy aligns with clinical guidelines

Ultimately, the right choice between Mounjaro and Wegovy depends on your preference for an injection versus a pill, how your body responds, and what fits best with your daily routine

Weeks 58: dose may increase

Can lifestyle changes alone prevent weight regain after stopping GLP-1

[1] If you accidentally inject more than your prescribed dose: Contact your healthcare provider or poison control center (1-800-222-1222) immediately Monitor for symptoms of hypoglycemia (shakiness, sweating, confusion, rapid heartbeat) if you take insulin or sulfonylureas Stay well-hydrated and avoid eating large meals, which may worsen nausea Seek emergency medical attention if you experience severe vomiting, signs of dehydration, severe abdominal pain, or altered consciousness Important safety considerations : Maintaining consistency in your dosing schedule optimizes therapeutic effects and minimizes side effects